Page last updated: 2024-08-23

etoposide and Hearing Loss, Sensorineural

etoposide has been researched along with Hearing Loss, Sensorineural in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (20.00)	18.7374
1990's	2 (40.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderson, D; Leonetti, JP; Marzo, S; Shirazi, MA	1
Chamberlain, MC; Glantz, MJ; Greenberg, HS; Wang, S	1
Castello, MA; Clerico, A; Deb, G; Dominici, C; Donfrancesco, A; Fidani, P	1
Castello, MA; Clerico, A; Dominici, C; Jenkner, A	1
Dallorso, S; De Bernardi, B; Dini, G; Moroni, C; Perin, G; Rogers, D; Stura, M	1

Reviews

1 review(s) available for etoposide and Hearing Loss, Sensorineural

Article	Year
Adult medulloblastoma: multiagent chemotherapy. Neuro-oncology, 2001, Volume: 3, Issue:1 Topics: Abdominal Pain; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebrospinal Fluid Shunts; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Gastrointestinal Diseases; Hearing Loss, Sensorineural; Hematologic Diseases; Humans; Infratentorial Neoplasms; Life Tables; Lomustine; Male; Medulloblastoma; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Peripheral Nervous System Diseases; Radiotherapy, Adjuvant; Retrospective Studies; Survival Analysis; Vincristine	2001

Article

Year

Adult medulloblastoma: multiagent chemotherapy.

Neuro-oncology, 2001, Volume: 3, Issue:1

Topics: Abdominal Pain; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebrospinal Fluid Shunts; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Gastrointestinal Diseases; Hearing Loss, Sensorineural; Hematologic Diseases; Humans; Infratentorial Neoplasms; Life Tables; Lomustine; Male; Medulloblastoma; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Peripheral Nervous System Diseases; Radiotherapy, Adjuvant; Retrospective Studies; Survival Analysis; Vincristine

2001

Other Studies

4 other study(ies) available for etoposide and Hearing Loss, Sensorineural

Article	Year
Neuroendocrine carcinoma of the jugular foramen. Ear, nose, & throat journal, 2008, Volume: 87, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Ataxia; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Cisplatin; Diagnosis, Differential; Etoposide; Female; Headache; Hearing Loss, Sensorineural; Humans; Jugular Veins; Magnetic Resonance Imaging; Middle Aged; Radiotherapy, Adjuvant; Radiotherapy, Intensity-Modulated; Skull Base Neoplasms; Tinnitus; Vertigo	2008
High-dose carboplatin in combination with etoposide (JET regimen) for childhood brain tumors. The American journal of pediatric hematology/oncology, 1990,Fall, Volume: 12, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Bone Marrow Diseases; Brain Neoplasms; Carboplatin; Child; Child, Preschool; Drug Evaluation; Etoposide; Glioblastoma; Hearing Loss, Sensorineural; Humans; Infant; Medulloblastoma; Remission Induction	1990
A pilot study of high-dose carboplatin and pulsed etoposide in the treatment of childhood solid tumors. Pediatric hematology and oncology, 1990, Volume: 7, Issue:2 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Child; Child, Preschool; Drug Evaluation; Etoposide; Female; Gastrointestinal Diseases; Hearing Loss, Sensorineural; Humans; Infant; Male; Neoplasms; Pilot Projects	1990
High-dose cisplatin and etoposide in advanced malignancies of childhood. Pediatric hematology and oncology, 1987, Volume: 4, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Child; Cisplatin; Drug Evaluation; Etoposide; Hearing Loss, Sensorineural; Humans; Neoplasms; Vomiting	1987